1. Home
  2. REPL vs RCAT Comparison

REPL vs RCAT Comparison

Compare REPL & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

SELL

Current Price

$10.82

Market Cap

1.3B

Sector

Health Care

ML Signal

SELL

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

BUY

Current Price

$4.71

Market Cap

1.3B

Sector

Industrials

ML Signal

BUY

Company Overview

Basic Information
Metric
REPL
RCAT
Founded
2015
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Wholesale Distributors
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
REPL
RCAT
Price
$10.82
$4.71
Analyst Decision
Buy
Strong Buy
Analyst Count
8
8
Target Price
★ $19.50
$16.50
AVG Volume (30 Days)
1.8M
★ 6.7M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $17,836,382.00
Revenue This Year
N/A
$270.70
Revenue Next Year
$497.81
$45.18
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 79.95
52 Week Low
$1.50
$4.41
52 Week High
$16.33
$18.78

Technical Indicators

Market Signals
Indicator
REPL
RCAT
Relative Strength Index (RSI) 32.47 19.44
Support Level $6.81 N/A
Resistance Level $11.05 $11.75
Average True Range (ATR) 0.71 0.27
MACD -0.20 -0.09
Stochastic Oscillator 1.83 13.20

Price Performance

Historical Comparison
REPL
RCAT

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Its suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities. The firm's Division includes Teal, FlightWave, and Blue Ops.

Share on Social Networks: